CI_with
has_DoseForm
has_Ingredient
has_MoA
has_PE
may_prevent
may_treat
drug associated with AE
Coronary Artery Disease [Disease/Finding]
Drug Hypersensitivity [Disease/Finding]
Gallbladder Diseases [Disease/Finding]
Hypercholesterolemia [Disease/Finding]
Hyperlipoproteinemias [Disease/Finding]
Liver Cirrhosis, Biliary [Disease/Finding]
Hypertriglyceridemia [Disease/Finding]
Liver Failure [Disease/Finding]
Kidney Failure [Disease/Finding]
Fenofibrate [Chemical/Ingredient]
Decreased Lipolysis [PE]
Unknown Cellular or Molecular Interaction [MoA]
[CV350] ANTILIPEMIC AGENTS
Oral Tablet [Dose Form]
FENOFIBRATE
FENOFIBRATE,MICRONIZED 48MG TAB [VA Product]
VA Product
C276961
C1533455
4017375
Fenofibrate 48 MG Oral Tablet
FENOFIBRATE,MICRONIZED 48MG TAB
0
<Product_Component>FENOFIBRATE</Product_Component><Strength>48</Strength><Unit>MG</Unit><VA.IEN>3766</VA.IEN>
FENOFIBRATE,MICRONIZED 48MG TAB
MG
<VANDF_Record>50.68^17012^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>17012</VA_IEN><VA_Status>Inactive/Master</VA_Status>
N0000165030
FENOFIBRATE TAB
非诺贝特微粉颗粒
48
477562
gastrointestinal disorder AE
muscle function disorder AE
skin allergy AE
severe rhabdomyolysis AE
FENOFIBRATE,MICRONIZED 48MG TAB [VA Product]
FENOFIBRATE,MICRONIZED 48MG TAB
VA Product
MG
<VANDF_Record>50.68^17012^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>17012</VA_IEN><VA_Status>Inactive/Master</VA_Status>
C276961
C1533455
N0000165030
FENOFIBRATE TAB
4017375
非诺贝特微粉颗粒
Fenofibrate 48 MG Oral Tablet
48
FENOFIBRATE,MICRONIZED 48MG TAB
0
<Product_Component>FENOFIBRATE</Product_Component><Strength>48</Strength><Unit>MG</Unit><VA.IEN>3766</VA.IEN>
477562